Genes4 Life Private Limited

Genes4 Life Private Limited - pharma in Bengaluru, Karnataka, India. Directors, charges & compliance details.
CIN U24290KA2022PTC158983 Incorporated 17 March 2022 ROC Bangalore HQ Bengaluru, Karnataka, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹2.51 Lakh
▼ 92% YoY
Net profit · FY 2025
₹70,934
Net margin 28.3%
EBITDA · FY 2025
₹95,858
EBITDA margin 38.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Genes4 Life Private Limited

Data last updated:

Genes4 Life Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 March 2022.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2022PTC158983.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Janardhanan and Anjali Madhusoodhanan.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No.D3 3rd Floor Sai Aster Apartment Balaji Enclave Ananthpura Yelahanka, Bengaluru, Karnataka, India – 560064.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.51 Lakh, a decline of 92% compared to the previous year. For the same year it recorded a net profit of ₹70,934 (net margin 28.3%) and EBITDA of ₹95,858 (EBITDA margin 38.2%).

Genes4 Life Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0282257). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24290KA2022PTC158983
Registration Number 158983
Incorporation Date 17 March 2022
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0282257

Recognitions & Rankings of Genes4 Life

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-KR-03-0282257

Contact details

Genes4 Life Private Limited's registered office is in Bengaluru, Karnataka.

  • Registered Address
    Flat No.D3 3rd Floor Sai Aster Apartment Balaji Enclave Ananthpura Yelahanka, Bengaluru, Karnataka, India – 560064
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Genes4 Life Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Genes4 Life is manufacturing. In detail, this covers manufacture of chemicals and chemical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing20Manufacture of chemicals and chemical products

To see the full business activity and turnover split of Genes4 Life Private Limited, buy the company report.

Financials of Genes4 Life Private Limited

FY 2025 filings available

Genes4 Life Private Limited reported revenue of ₹2.51 Lakh (down 92% YoY) for FY 2025.

Revenue · FY 2025
₹2.51 Lakh ▼ 92%
Net profit · FY 2025
₹70,934 margin 28.3%
EBITDA · FY 2025
₹95,858 margin 38.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 92%
EBITDA CAGR growth
1 year
▼ 5%

Revenue fell 92% in the latest year. EBITDA fell 5% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹95,858
Profit Before Tax
Tax Expense
Net Profit (PAT)₹70,934
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin38.2%
Net Profit Margin28.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Genes4 Life Private Limited, buy the company report.

Board of directors of Genes4 Life Private Limited

Genes4 Life has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
JanardhananDirector17 Mar 20224 Years 7 MonthsCurrent
Anjali MadhusoodhananDirector01 Mar 20233 Years 8 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Genes4 Life Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Genes4 Life Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Genes4 Life Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Anjali Madhusoodhanan ceased to be Additional Director on 29 Dec 2023.

AGM
Genes4 Life Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Genes4 Life Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Anjali Madhusoodhanan ceased to be Additional Director.
Ceased
Chengazhasseri Illom Kesavan Elayathu Anjana ceased to be Director.
Appointed
Anjali Madhusoodhanan was appointed as Director.
Appointed
Janardhanan was appointed as Director.
Incorporation
17 Mar 2022
Genes4 Life Private Limited was registered on 17 Mar 2022 with Roc Bangalore & aged 4 years 7 months as per MCA records.

Frequently asked questions

Genes4 Life is an active private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 March 2022 (4+ years old) and is registered under CIN U24290KA2022PTC158983.

Genes4 Life has 2 current directors:

The latest financial statements of Genes4 Life on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Genes4 Life is U24290KA2022PTC158983. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Genes4 Life was incorporated on 17 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.

Anjali Madhusoodhanan ceased to be Additional Director on 29 Dec 2023. Chengazhasseri Illom Kesavan Elayathu Anjana ceased to be Director on 02 Mar 2023. Anjali Madhusoodhanan was appointed as Director on 01 Mar 2023. Genes4 Life has 4 board changes on record in total.

Yes, Genes4 Life is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0282257).

The registered office of Genes4 Life is at Flat No.D3 3rd Floor Sai Aster Apartment Balaji Enclave Ananthpura Yelahanka, Bengaluru, Karnataka, India – 560064.

Genes4 Life operates in the pharma industry, in the drug formulation and development segment.

The compliance status of Genes4 Life is compliant as of 25 July 2026. The company is actively filing with the Registrar of Companies.